Paul Hastings advised Spectrum Pharmaceuticals, Inc. on the deal Spectrum Pharmaceuticals, Inc. executed the sale of seven FDA-approved hematology/oncology products to Acrotech Biopharma LLC, a subsidiary…
Acrotech Biopharma’s $300 Million Acquisition of Spectrum Pharmaceuticals’ Hematology/Oncology Portfolio
